Volume 272, Number 39,
Issue of September 26, 1997
pp. 24703-24709
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Abnormal Protein Tyrosine Phosphorylation in Fibroblasts from
Hyperapobetalipoproteinemia Subjects
(Received for publication, June 16, 1997, and in revised form, July 28, 1997)
Mahnaz
Motevalli
,
Pascal J.
Goldschmidt-Clermont
§
,
Donna
Virgil
and
Peter O.
Kwiterovich
Jr.
From the
Lipid Research Atherosclerosis Unit,
§ Division of Cardiology, Bernard Laboratory, Departments of
Pediatrics and Medicine, The Johns Hopkins University School of
Medicine, Baltimore, Maryland 21287-3654
The stimulatory effects of three normal human
serum basic proteins (BP), BP I (Mr 14,000, pI
9.10), BP II (Mr 27, 500, pI 8.48), and BP III
(Mr 55,000, pI 8.73) on cellular triglyceride and cholesterol formation require intact protein-tyrosine kinase phosphorylation (TKP). Here we examined whether there is an abnormality in TKP in cultured fibroblasts from 11 patients with
hyperapobetalipoproteinemia (hyperapoB) that manifest two
acylation-stimulatory defects, decreased stimulation of
triglyceride synthesis by BP I but enhanced formation of
cholesterol by BP II. Soluble and insoluble proteins in Triton X-100
extracts were isolated by immunoprecipitation with a monoclonal anti-phosphotyrosine antibody (MAPA) bound to agarose beads and by
ultracentrifugation, respectively, from confluent fibroblasts after
incubation for 24 h in supplemented serum-free and lipid-free medium (DMEM/F12). Western blots of insoluble proteins showed that
group (Gp) II (Mr 36,000-55,000) and Gp III
(Mr 14,000-35,000) from hyperapoB cells, grown
in DMEM/F12 medium without BP, had significantly decreased reactivity
to MAPA. No significant differences in reactivity to MAPA were detected
between normal and hyperapoB cells for Gp I (Mr
97-120,000). BP II, but not BP I or BP III, reversed the decreased
reactivity of Gp II and Gp III to MAPA in hyperapoB cells. Sodium
vanadate, an inhibitor of phosphotyrosine phosphatases, did not reverse
the deficiency in TKP or the 50% deficiency in the stimulation of mass
triglyceride by BP I in hyperapoB cells. Tyrosine-phosphorylated Erk-2,
a mitogen-activated protein kinase, identified as one of the proteins
in Gp II, was significantly decreased in hyperapoB cells. These results
provide further evidence for abnormal protein TKP in hyperapoB cells
and suggest a possible link between atherosclerotic changes in
hyperapoB patients and growth factors upstream from mitogen-activated
protein kinase.